SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-043819
Filing Date
2017-02-14
Accepted
2017-02-14 17:37:19
Documents
1
Group Members
ANDREW MARTINDAWN FITZPATRICKKEVIN RUSSELL

Document Format Files

Seq Description Document Type Size
1 SC 13G d347796dsc13g.htm SC 13G 81761
  Complete submission text file 0001193125-17-043819.txt   83563
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 17610967
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

IRS No.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G